Products containing mainly or only cannabidiol demonstrated almost no ability to manage a person's pain, a review of clinical ...

According to a recent review published in the journal Current Neuropharmacology, the use of cannabidiol (CBD), the non-intoxicating component of cannabis, has been associated with numerous adverse ...

Uncover how this plant-derived compound could revolutionize cognitive health, offering new hope for anxiety and cognitive impairment - if future research confirms its full potential. Study: ...

Parkinson's disease (PD) is a neurodegenerative disorder caused by the loss of nerve cells in a part of the brain called substantia nigra. This anomaly affects the level of dopamine. Dopamine is a ...

A drug from GW Pharmaceuticals plc GWPH targeting a cause of genetic epilepsy has received Priority Review status from the U.S. Food and Drug Administration. The Cambridge, U.K.-based company and its ...